Changes in Cardiac Varices and Their Clinical Significance after Eradication of Esophageal Varices by Band Ligation

Table 1

Baseline characteristics of patients who underwent EVs eradication by EBL—arranged according to the type of varices.

	All patients ()	Pts with EVs only ()	Pts with GOV1s ()	P
Age				0.347
Male, (%)	96 (78.0)	27 (71.1)	69 (81.2)	0.210
Etiology, (%)				0.158
Hepatitis B virus	41 (33.3)	9 (23.7)	32 (37.6)
Hepatitis C virus	10 (8.1)	4 (10.5)	6 (7.1)
Alcohol	59 (48.0)	23 (60.5)	36 (42.4)
Others	13 (10.6)	2 (5.3)	11 (12.9)
Purpose of EBL, (%)				0.445
Primary prophylaxis	71 (57.7)	20 (52.6)	51 (60.0)
Secondary prophylaxis	52 (42.3)	18 (47.4)	34 (40.0)
Size of EVs				0.639
F2	104 (84.6)	33 (86.8)	71 (83.5)
F3	19 (15.4)	5 (13.2)	14 (16.5)
Red color sign on EVs, (%)	117 (95.1)	35 (92.1)	82 (96.5)	0.299
Number of EBL sessions	2.3 ± 1.0	2.1 ± 1.2	2.4 ± 0.8	0.112
Number of used rubber bands	7.7 ± 3.6	7.3 ± 5.0	7.9 ± 2.7	0.456
Duration until EVs eradiation, months	2.4 ± 1.4	2.2 ± 1.7	2.5 ± 1.2	0.288
Platelet count, ×10^9/L	89.1 ± 45.2	93.0 ± 44.5	87.3 ± 45.6	0.526
INR	1.4 ± 0.3	1.4 ± 0.3	1.4 ± 0.3	0.362
AST, IU/L	89.8 ± 182.7	69.7 ± 59.6	98.8 ± 216.0	0.416
ALT, IU/L	41.9 ± 55.3	34.0 ± 25.1	45.4 ± 64.2	0.295
Bilirubin, mg/dL	1.7 ± 1.4	1.8 ± 1.3	1.7 ± 1.5	0.572
Albumin, g/dL	3.2 ± 0.6	3.1 ± 0.5	3.2 ± 0.6	0.287
Creatinine, mg/dL	1.0 ± 0.9	0.9 ± 0.3	1.0 ± 1.1	0.373
Sodium, mEq/L	137.7 ± 4.7	137.6 ± 4.6	137.7 ± 4.7	0.905
Ascites, (%)	65 (52.8)	49 (57.6)	16 (42.1)	0.111
Encephalopathy, (%)	10 (8.1)	1 (2.6)	9 (10.6)	0.136
Child-Pugh score	7.2 ± 1.7	7.2 ± 1.6	7.2 ± 1.8	0.908
Child-Pugh classification, (%)				0.943
Grade A	50 (40.7)	16 (42.1)	34 (40.0)
Grade B	61 (49.6)	18 (47.4)	43 (50.6)
Grade C	12 (9.8)	4 (10.5)	8 (9.4)

AST: aspartate aminotransferase; ALT: alanine aminotransferase; EBL: endoscopic band ligation; EVs: esophageal varices; GOVs: gastroesophageal varices; INR: international normalized ratio.